Pharmaceutical pricing benchmarks: governmental versus private sector

被引:2
|
作者
Turkistani, Fatema [1 ]
Bin Sawad, Aseel [2 ]
机构
[1] Taibah Univ, Coll Pharm, Clin & Hosp Pharm Dept, Medina, Saudi Arabia
[2] Umm Al Qura Univ, Coll Pharm, Clin Pharm Dept, Mecca, Saudi Arabia
关键词
California; Medi-Cal; price; pricing benchmark; workers' compensation; DRUG COSTS;
D O I
10.2217/cer-2020-0106
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose:To explore the best pricing benchmark for workers' compensation drugs reimbursement at retail pharmacies.Materials & methods:We used California workers' compensation system (CAWCS) total cost of pharmacy dispensed medications (2017-2019) as a proxy to estimate drug prices using alternative pricing mechanism fee schedules.Results:CAWCS paid 65.6% of the average wholesale price (AWP), 104.1% of Medi-Cal, 122.1% of the wholesale acquisition cost (WAC), 140.1% of the national average drug acquisition cost (NADAC), and 253.5% of the federal upper limit. In addition, we found the AWP-based formulas: CAWCS = AWP - 34.4%, Medi-Cal = AWP - 36.9%, WAC = AWP - 46.3%, NADAC = AWP - 53.2%, and federal upper limit = AWP - 74.1%. We found that AWP: 50% for generics and AWP - 18.2% for brands are the lowest paying formulas. The estimated median cost savings were $8.7 million (by adapting 97% of the WAC) and $9.5 million (by adapting the NADAC) across all states.Conclusion:NADAC was the best pricing benchmark for reimbursement of pharmacy dispensed drugs.
引用
收藏
页码:1091 / 1100
页数:10
相关论文
共 50 条